Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06346106 · ClinicalTrials.gov registry record

The Diagnostic Experience of Male Rett Syndrome

A clinical trial of Rett Syndrome and RTT, sponsored by Children's Hospital Colorado.

Recruiting
Registry status
80
Enrollment target
1
Study location

NCT06346106 is a study of Rett Syndrome and RTT that is actively recruiting participants, run by Children's Hospital Colorado. The registered enrollment target is 80 participants, below the 521-participant average among 18 other Rett Syndrome trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06346106, a study of Rett Syndrome and RTT, is actively recruiting participants, sponsored by Children's Hospital Colorado.

RECRUITING
Registry status
80 participants
Enrollment target
1
Study location

Study Summary

The Diagnostic Experience of Male Rett Syndrome collects information on the lived experiences of parents or caregivers to boys with Rett Syndrome. Key information examined includes the process of getting a male Rett syndrome diagnosis, your son's systems of care, and your priorities for his health needs. Enrolled participants will complete an online survey with questions about having a son with Rett Syndrome. The Diagnostic Experience of Male Rett Syndrome study is available to parents or caregivers to boys (alive or passed) with Rett Syndrome. Compensation is not provided.

Conditions Studied

Interventions

  • GENETIC Male Rett

Study Locations (1)

Colorado

  • University of Colorado Anschutz Medical Campus - Aurora

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2023-05-24
Est. Completion 2024-04-30

Sponsor

Children's Hospital Colorado

7 total trials

What the Registry Record Tells You About NCT06346106

The ClinicalTrials.gov registry entry for NCT06346106 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 521-participant average among 18 other Rett Syndrome trials with a reported enrollment target (85% lower). The listed sponsor is Children's Hospital Colorado, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Rett Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Male Rett is the first listed.

NCT06346106 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06346106 about?

NCT06346106 is a clinical study titled "The Diagnostic Experience of Male Rett Syndrome". The Diagnostic Experience of Male Rett Syndrome collects information on the lived experiences of parents or caregivers to boys with Rett Syndrome. Key information examined includes the process of getting a male Rett syndrome diagnosis, your son's systems of care, and your priorities for his health n...

What is the current status of trial NCT06346106?

This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2023-05-24. Estimated completion is 2024-04-30.

What conditions does trial NCT06346106 study?

This clinical trial studies the following conditions: Rett Syndrome, RTT.

What interventions are being tested in trial NCT06346106?

The interventions under investigation include: Male Rett (GENETIC).

Who is sponsoring clinical trial NCT06346106?

This trial is sponsored by Children's Hospital Colorado, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06346106 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rett Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.